Subclinical atherosclerosis is inversely associated with gray matter volume in african americans with type 2 diabetes

Diabetes Care

Volumn 38, Issue 11, 2015, Pages 2158-2165

  Freedman, Barry I ^a   Divers, Jasmin ^a   Whitlow, Christopher T ^a   Bowden, Donald W ^a   Palmer, Nicholette D ^a   Smith, S Carrie ^a   Xu, Jianzhao ^a   Register, Thomas C ^a   Carr, J Jeffrey ^b   Wagner, Benjamin C ^a   Williamson, Jeff D ^a   Sink, Kaycee M ^a   Maldjian, Joseph A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL;

ADULT; AFRICAN AMERICAN; AORTA ATHEROSCLEROSIS; ARTICLE; BRAIN SIZE; CAROTID ATHEROSCLEROSIS; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; GRAY MATTER; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MODIFIED MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BLOOD LEVEL; VOLUMETRY; AGED; ANALYSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; COGNITION DISORDERS; COMPLICATION; DIAGNOSTIC IMAGING; ETHNOLOGY; GLUCOSE BLOOD LEVEL; ORGAN SIZE; PATHOLOGY; RADIOGRAPHY;

AFRICAN AMERICANS; AGED; ATHEROSCLEROSIS; BLOOD GLUCOSE; COGNITION; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; PLAQUE, ATHEROSCLEROTIC; RADIOGRAPHY;

EID: 84962368272     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-1035     Document Type: Article

References (42)

1. van der Veen PH, Muller M, Vincken KL, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group. Brain volumes and risk of cardiovascular events and mortality. The SMART-MR study. Neurobiol Aging 2014;35:1624-1631.
2. Tiehuis AM, van der Graaf Y, Mali WP, Vincken K, Muller M, Geerlings MI; SMART Study Group. Metabolic syndrome, prediabetes, and brain abnormalities on MRI in patients with manifest arterial disease: The SMART-MR study. Diabetes Care 2014;37:2515-2521.
3. Kooistra M, Geerlings MI, van der Graaf Y, et al.; SMART-MR Study Group. Vascular brain lesions, brain atrophy, and cognitive decline. The Second Manifestations of ARTerial disease- Magnetic Resonance (SMART-MR) study. Neurobiol Aging 2014;35:35-41.
4. Karcher HS, Holzwarth R, Mueller HP, et al. Body fat distribution as a risk factor for cerebrovascular disease: An MRI-based body fat quantification study. Cerebrovasc Dis 2013;35: 341-348.
5. Kral BG, Nyquist P, Vaidya D, et al. Relation of subclinical coronary artery atherosclerosis to cerebral white matter disease in healthy subjects from families with early-onset coronary artery disease. Am J Cardiol 2013;112: 747-752.
6. Freedman BI, Divers J, Palmer ND. Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures. Am J Kidney Dis 2013;62:1165-1175.
7. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA 2002;287:2519-2527.
8. Young BA, Maynard C, Boyko EJ. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care 2003; 26:2392-2399.
9. Young BA, Rudser K, Kestenbaum B, Seliger SL, Andress D, Boyko EJ. Racial and ethnic differences in incident myocardial infarction in end-stage renal disease patients: The USRDS. Kidney Int 2006;69:1691-1698.
10. Wassel CL, Pankow JS, Peralta CA, Choudhry S, Seldin MF, Arnett DK. Genetic ancestry is associated with subclinical cardiovascular disease in African-Americans and Hispanics from the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Genet 2009;2:629-636.
11. Divers J, Palmer ND, Lu L, et al. Admixture mapping of coronary artery calcified plaque in AfricanAmericans with type 2 diabetes mellitus. Circ Cardiovasc Genet 2013;6:97-105.
12. Keaton JM, Cooke Bailey JN, Palmer ND, et al. A comparison of type 2 diabetes risk allele load between African Americans and European Americans. Hum Genet 2014;133:1487-1495.
13. Palmer ND, Sink KM, Smith SC, et al. Kidney disease and cognitive function: African American- Diabetes Heart Study MIND. Am J Nephrol 2014; 40:200-207.
14. Sink KM, Divers J, Whitlow CT, et al. Cerebral structural changes in diabetic kidney disease: African American-Diabetes Heart Study MIND. Diabetes Care 2015;38:206-212.
15. Freedman BI, Wagenknecht LE, Hairston KG, et al. Vitamin D, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab 2010;95:1076-1083.
16. Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
17. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318.
18. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-699.
19. Detrano RC, Anderson M, Nelson J, et al. Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibilitydMESA study. Radiology 2005; 236:477-484.
20. Ashburner J, Friston KJ. Voxel-based morphometrydthe methods. Neuroimage 2000;11:805-821.
21. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273-289.
22. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003;19:1233- 1239.
23. Schmidt P, Gaser C, Arsic M, et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis. Neuroimage 2012;59:3774-3783.
24. Maldjian JA, Whitlow CT, Saha BN, et al. Automated white matter total lesion volume segmentation in diabetes. AJNR Am J Neuroradiol 2013;34:2265-2270.
25. Jovicich J, Czanner S, Han X, et al. MRIderived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. Neuroimage 2009;46:177-192.
26. Han X, Jovicich J, Salat D, et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer. Neuroimage 2006;32:180-194.
27. Pendlebury ST, Mariz J, Bull L, Mehta Z, Rothwell PM. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke. Stroke 2012;43:464-469.
28. Huber PJ. Robust regression: Asymptotics, conjectures and Monte Carlo. Ann Stat 1973;5:799-821.
29. Box GEP, Cox DR. An analysis of tranformations. J R Stat Soc Ser B 1964;26:211-252.
30. Reilly MP, Wolfe ML, Localio AR, Rader DJ. Coronary artery calcification and cardiovascular risk factors: impact of the analytic approach. Atherosclerosis 2004;173:69-78.
31. Moskvina V, Schmidt KM. On multipletesting correction in genome-wide association studies. Genet Epidemiol 2008;32:567-573.
32. van der Veen PH, Muller M, Vincken KL, et al.; SMART-MR Study Group. Longitudinal changes in brain volumes and cerebrovascular lesions on MRI in patients with manifest arterial disease: The SMART-MR study. J Neurol Sci 2014;337:112-118.
33. Newman AB, Naydeck BL, Sutton-Tyrrell K, et al. Relationship between coronary artery calcification and other measures of subclinical cardiovascular disease in older adults. Arterioscler Thromb Vasc Biol 2002;22:1674-1679.
34. Freedman BI, Hsu FC, Langefeld CD, et al. The impact of ethnicity and sex on subclinical cardiovascular disease: The Diabetes Heart Study. Diabetologia 2005;48:2511-2518.
35. Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary calcification: The Multi- Ethnic Study of Atherosclerosis (MESA). Circulation 2005;111:1313-1320.
36. Carnethon MR, Bertoni AG, Shea S, et al. Racial/ethnic differences in subclinical atherosclerosis among adults with diabetes: The Multi- Ethnic Study of Atherosclerosis. Diabetes Care 2005;28:2768-2770.
37. Budoff MJ, Nasir K, Mao S, et al. Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis 2006;187: 343-350.
38. Divers J, Hugenschmidt C, Sink KM, et al. Cerebral white matter hyperintensity in African Americans and European Americans with type 2 diabetes. J Stroke Cerebrovasc Dis 2013;22: e46-e52.
39. Weiner DE, Bartolomei K, Scott T, et al. Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis 2009;53:438-447.
40. Aggarwal NT, Wilson RS, Bienias JL, et al. The association ofmagnetic resonance imagingmeasures with cognitive function in a biracial population sample. Arch Neurol 2010;67:475-482.
41. Brickman AM, Schupf N, Manly JJ, et al. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol 2008;65:1053-1061.
42. Hugenschmidt CE, Hsu FC, Hayasaka S, et al. The influence of subclinical cardiovascular disease and related risk factors on cognition in type 2 diabetes mellitus: The DHS-Mind study. J Diabetes Complications 2013;27:422-428.